Reported Oct 10, 2012 · Terminated
Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per…
Caraco Pharmaceutical Laboratories Ltd.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Caraco Pharmaceutical Laboratories Ltd. · 270 Prospect Plains Rd · Cranbury, NJ · 08512-3605
Is this the product you have?
- Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65
- Distributed byCaraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc
- Lot codes and dates
- Lot
a) 3305.039BExp 07/13b) 3305.039AExp 07/13
- Lot
- Amount recalled
- a) 2424 Cartons b) 2675 Cartons
Where it was sold
Why it was recalled
Crystallization: Presence of crystals of Nimodipine within the capsule solution.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Caraco Pharmaceutical Laboratories Ltd. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.